Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-06-30

Clinical Trial Update: Tenofovir DF + Efavirenz (TDF+EFV) Versus Tenofovir DF + Efavirenz + Lamivudine (TDF+EFV+3TC) Maintenance Regimen in Virologically Controlled Patients: COOL Trial [Phase 4]

View source ↗

Summary

This Phase 4 trial compares continuing tenofovir disoproxil fumarate plus efavirenz versus adding lamivudine to the regimen as a maintenance strategy in virolog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epivir (lamivudine) (lamivudine)
  • Sustiva (efavirenz) (efavirenz)
  • Viread (Tenofovir disoproxil fumarate) (Tenofovir disoproxil fumarate)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV Infections | Phase 4 | Status: COMPLETED